ArticleRSC advances2018

Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy.

Yu Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.